jueves, 10 de julio de 2014

National Guideline Clearinghouse | Fabry disease practice guidelines: recommendations of the National Society of Genetic Counselors.

full-text ►

National Guideline Clearinghouse | Fabry disease practice guidelines: recommendations of the National Society of Genetic Counselors.



National Society of Genetic Counselors

National Guideline Clearinghouse (NGC)

Guideline Title
Fabry disease practice guidelines: recommendations of the National Society of Genetic Counselors.
Bibliographic Source(s)
Laney DA, Bennett RL, Clarke V, Fox A, Hopkin RJ, Johnson J, O'Rourke E, Sims K, Walter G. Fabry disease practice guidelines: recommendations of the National Society of Genetic Counselors. J Genet Couns. 2013 Oct;22(5):555-64. [71 references] PubMed External Web Site Policy
Guideline Status
This is the current release of the guideline.
This guideline updates a previous version: Bennett RL, Hart KA, O'Rourke E, Barranger JA, Johnson J, MacDermot KD, Pastores GM, Steiner RD, Thadhani R. Fabry disease in genetic counseling practice: recommendations of the National Society of Genetic Counselors. 2002 Apr;11(2):121-46.
 2013 Oct;22(5):555-64. doi: 10.1007/s10897-013-9613-3. Epub 2013 Jul 17.

Fabry disease practice guidelines: recommendations of the National Society of Genetic Counselors.

Abstract

Identification and comprehensive care of individuals who have Fabry disease (FD) requires a multidisciplinary approach inclusive of genetic testing, test interpretation, genetic counseling, long term disease symptom monitoring, treatment recommendations, and coordination of therapy. The purpose of this document is to provide health care professionals with guidelines for testing, care coordination, identification of psychosocial issues, and to facilitate a better understanding of disease treatment expert recommendations for patients with Fabry disease. These recommendations are the opinions of a multicenter working group of genetic counselors, medical geneticists, and other health professionals with expertise in Fabry disease counseling, as well as representatives/founders of the two United States based Fabry disease patient advocacy groups who are themselves affected by Fabry disease. The recommendations are U.S. Preventive Task Force Class III, and they are based on clinical experience, a review of pertinent English-language articles, and reports of expert committees. This document reviews the genetics of Fabry disease, the indications for genetic testing, interpretation of results, psychosocial considerations, and references to professional and patient resources.

PMID:
 
23860966
 
[PubMed - indexed for MEDLINE]

No hay comentarios:

Publicar un comentario